Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy

被引:45
|
作者
Odze, R. D. [1 ]
Lauwers, G. Y. [2 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
10.1055/s-0028-1103416
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This review focuses on the histopathological evaluation of endoscopic mucosal resection (EMR) specimens in Barrett's esophagus, and on the histopathological, biological, and molecular properties of postablation Barrett's esophagus. EMR may be used for both diagnostic and therapeutic purposes. Diagnostic accuracy regarding the grade and stage of neoplasms is improved with the use of EMR, but the value of this technique for treatment is more controversial because of the high prevalence rate of positive margins and the rate of metachronous lesions found elsewhere in the esophagus during follow-up. Ablation techniques, such as argon plasma coagulation, photodynamic therapy, and radiofrequency ablation, are used increasingly for the treatment of Barrett's esophagus and related neoplasms, often in combination with EMR. A common problem after use of these techniques is the development of islands of neosquamous epithelium (NSE) which can overlie buried Barrett's (and/or dysplasia) epithelium. This is, therefore, concealed to the endoscopist's view and may be allowed to progress to cancer without detection. NSE is histologically similar to normal esophageal squamous epithelium and does not possess the molecular aberrations characteristic of Barrett's esophagus. In contrast, residual nonburied Barrett's esophagus shows persistent pathologic and molecular abnormalities and may progress to cancer upon long term followup. The biological potential and rate of progression of nonburied residual Barrett's esophagus following ablation is unclear, but some preliminary studies suggest that the risk may decrease. Buried nondysplastic Barrett's esophagus appears to show decreased biological potential and this may be related to protection from the contents of the lumen by the barrier function of the overlying NSE. On the other hand, anecdotal reports have suggested that buried dysplasia may progress to cancer in some instances. © Georg Thieme Verlag KG Stuttgart.
引用
收藏
页码:1008 / 1015
页数:8
相关论文
共 50 条
  • [41] Endoscopic Treatments for Dysplastic Barrett’s Esophagus: Resection, Ablation, What Else?
    Charumathi Raghu Subramanian
    George Triadafilopoulos
    World Journal of Surgery, 2015, 39 : 597 - 605
  • [42] Endoscopic Treatments for Dysplastic Barrett's Esophagus: Resection, Ablation, What Else?
    Subramanian, Charumathi Raghu
    Triadafilopoulos, George
    WORLD JOURNAL OF SURGERY, 2015, 39 (03) : 597 - 605
  • [43] Endoscopic mucosal resection (EMR) followed by radiofrequency ablation (RFA) in neoplastic Barrett's esophagus or Barrett early cancer is also economically superior to sole radical endoscopic resection
    Wilke, M.
    Rathmayer, M.
    Schenker, M.
    Schepp, W.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (05): : 416 - 420
  • [44] Mucosal ablation of Barrett esophagus
    Waxman, Irving
    Konda, Vani J. A.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (07) : 393 - 401
  • [45] Mucosal ablation of Barrett esophagus
    Irving Waxman
    Vani J. A. Konda
    Nature Reviews Gastroenterology & Hepatology, 2009, 6 : 393 - 401
  • [46] Radiofrequency ablation and endoscopic mucosal resection in Barrett's esophagus with early neoplasia. Can we avoid complications?
    Conio, M.
    Fisher, D. A.
    Palazzo, L.
    ENDOSCOPY, 2013, 45 (06) : 506 - 506
  • [47] Safety and Effectiveness of Radiofirequency Ablation (RFA) in Combination with Endoscopic Mucosal Resection (EMR) for Barrett's Esophagus and Associated Neoplasia
    Shin, Eun Ji
    Jagannath, Sanjay B.
    Dunbar, Kerry B.
    Lennon, Anne Marie
    Gorospe, Emmanuel C.
    Montgomery, Elizabeth A.
    Canto, Marcia I.
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB354 - AB354
  • [48] Benefit of radiofrequency ablation after widespread endoscopic resection of neoplastic Barrett's esophagus in daily practice
    Godat, Sebastien
    Marx, Mariola
    Caillol, Fabrice
    Robert, Maxime
    Autret, Aurelie
    Bories, Erwan
    Pesenti, Christian
    Ratone, Jean Philippe
    Schoepfer, Alain
    Poizat, Flora
    Giovannini, Marc
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (01): : 34 - 41
  • [49] Eradication of neoplastic Barrett's esophagus in patients with esophageal varices with a modified endoscopic mucosal resection technique and radiofrequency ablation
    Uchima, Hugo
    Ble, Michel
    Busquets, David
    Serra, Isabel
    Lopez, Carmen
    Aldeguer, Xavier
    Huertas, Carlos
    ENDOSCOPY, 2022, 54 (06) : E261 - E263
  • [50] Endoscopic surveillance or ablation for Barrett's esophagus?
    Inadomi, John M.
    Saxena, Nina
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3